---
figid: PMC9501361__metabolites-12-00826-g004
figtitle: 'Review of Oxylipins in Alzheimer’s Disease and Related Dementias (ADRD):
  Potential Therapeutic Targets for the Modulation of Vascular Tone and Inflammation'
organisms:
- Glycine max
- Candida dubliniensis
- Curcuma longa
- Carthamus tinctorius
- Perilla frutescens
- Mus musculus
- Rattus norvegicus
- Homo sapiens
- gut metagenome
- Sardina pilchardus
organisms_ner:
- Drosophila melanogaster
pmcid: PMC9501361
filename: metabolites-12-00826-g004.jpg
figlink: /pmc/articles/PMC9501361/figure/metabolites-12-00826-f004/
number: F4
caption: 'Schematic diagram of oxylipins and associated clinical outcomes. Highlights
  of the major oxidation pathways for linoleic acid (LA), eicosapentaenoic acid (EPA),
  and docosahexaenoic acid (DHA) that include cytochrome P450 (P450 pathway)-soluble
  epoxide hydrolase (sEH), and lipoxygenase (LOX pathway) that are associated with
  clinical outcomes associated with ADRD and ADRD risk listed in . First author and
  references included for clinical outcomes: Diabetic Retinopathy, Zhao et al. [],
  Hu et al. []; Alzheimer’s Disease, Borkowski et al. []; Brain MRI Ischemic Markers
  (White Matter Hyperintensity), Yu et al. [], Shinto et al. []; Heart Disease, Zhang
  et al. [], Kim-Campbell et al. []; Ischemic stroke, Szczuko et al. []; Inflammation,
  Vasoactivity, Kim-Campbell et al. []; Atherosclerosis, Kuhn et al. [], Waddington
  et al. [], Shibata et al. []; Blood Pressure, Caligiuri et al. []; Cognition, Yu
  et al. [], Shinto et al. [], Borkowski et al. [].'
papertitle: 'A Review of Oxylipins in Alzheimer’s Disease and Related Dementias (ADRD):
  Potential Therapeutic Targets for the Modulation of Vascular Tone and Inflammation.'
reftext: Lynne H. Shinto, et al. Metabolites. 2022 Sep;12(9):826.
year: '2022'
doi: 10.3390/metabo12090826
journal_title: Metabolites
journal_nlm_ta: Metabolites
publisher_name: MDPI
keywords: review | oxylipin | fatty acids | vascular dementia | Alzheimer’s disease
automl_pathway: 0.9160181
figid_alias: PMC9501361__F4
figtype: Figure
redirect_from: /figures/PMC9501361__F4
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9501361__metabolites-12-00826-g004.html
  '@type': Dataset
  description: 'Schematic diagram of oxylipins and associated clinical outcomes. Highlights
    of the major oxidation pathways for linoleic acid (LA), eicosapentaenoic acid
    (EPA), and docosahexaenoic acid (DHA) that include cytochrome P450 (P450 pathway)-soluble
    epoxide hydrolase (sEH), and lipoxygenase (LOX pathway) that are associated with
    clinical outcomes associated with ADRD and ADRD risk listed in . First author
    and references included for clinical outcomes: Diabetic Retinopathy, Zhao et al.
    [], Hu et al. []; Alzheimer’s Disease, Borkowski et al. []; Brain MRI Ischemic
    Markers (White Matter Hyperintensity), Yu et al. [], Shinto et al. []; Heart Disease,
    Zhang et al. [], Kim-Campbell et al. []; Ischemic stroke, Szczuko et al. []; Inflammation,
    Vasoactivity, Kim-Campbell et al. []; Atherosclerosis, Kuhn et al. [], Waddington
    et al. [], Shibata et al. []; Blood Pressure, Caligiuri et al. []; Cognition,
    Yu et al. [], Shinto et al. [], Borkowski et al. [].'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Cyp4g1
  - Cyp4d1
  - Cyp4d2
  - Cyp4ae1
  - Cyp18a1
  - Cpr
  - Cyp4e3
  - Cyp6a2
  - Cyp9b1
  - Cyp9b2
  - Cyp4e2
  - Cyp6a9
  - Cyp6a20
  - Cyp6a21
  - Cyp6a8
  - Cyp9c1
  - Cyp4d8
  - Cyp12a4
  - Cyp4c3
  - Cyp4e1
  - Cyp4p1
  - Cyp6a22
  - La
  - Pka-R2
  - Loxl2
  - Loxl1
  - mri
  - .na.character
---
